ArticleNature biotechnology2016
A community-based model of rapid autopsy in end-stage cancer patients.
Abstract readLetter
In one paragraph
Article in Nature biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.
0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed.
- Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.Nature communications · 2026Article
- Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer.Genome biology · 2026Article
- Variable cellular and radiobiological effects of [Journal of experimental & clinical cancer research : CR · 2026Article
- Experts' attitudes towards 'targeted autopsies' using qualitative interviews in a medical network in Germany.BMJ open · 2025Article
- 'Finding Comfort in Discomfort': A Qualitative Study of Cancer Clinicians and Researchers' Experiences of Conducting a Cancer Rapid Autopsy Program.Psycho-oncology · 2025Article
- FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.Nature communications · 2024Article
- Research autopsy programmes in oncology: shared experience from 14 centres across the world.The Journal of pathology · 2024Article
- Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program.NPJ breast cancer · 2024Article
- Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models.Nature communications · 2023Article
- Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.Nature communications · 2023Article
- Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy.The Journal of clinical investigation · 2023Article
- Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United States.Journal of virus eradication · 2023Article
- Lessons learned from the Last Gift study: ethical and practical challenges faced while conducting HIV cure-related research at the end of life.Journal of medical ethics · 2023Article
- Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.Current HIV/AIDS reports · 2022Review
- Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.Cancers · 2022Article
- Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method Study.AIDS research and human retroviruses · 2022Article
- Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States.BMC medical ethics · 2022Article
- High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.SLAS discovery : advancing life sciences R & D · 2021Article
- The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.Nature communications · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
65 authors.
Kathryn AlsopCancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Heather ThorneCancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Shahneen SandhuDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Anne HamiltonDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Christopher MintoffCancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia.
Elizabeth ChristieCancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-9959-7024
Odette SpruytDepartment of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
Scott WilliamsDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Orla McNallyDepartment of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia.
Linda MileshkinDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sumitra AnandaDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Julene HalloDepartment of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia.
Sherene LoiDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Clare ScottThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Peter SavasDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Lisa DevereuxSir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.
Patricia O'BrienThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Sameera GunawardenaThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.ORCID 0000-0001-9562-0533
Clare HampsonThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Kate StrachanThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Rufaro Diana JaravazaThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Victoria FrancisThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Gregory YoungThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
David RansonThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Ravindra SamaranayakeThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
David StevensTobin Brothers Funerals, Victoria, Australia.
Samantha BoyleCancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia.
Clare FedeleCancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia.
Monique ToppThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Gwo HoThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Zhi Ling TeoSir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.
Renea A TaylorDepartment of Physiology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia.
Melissa M PapargirisDepartment of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia.
Mitchell G LawrenceDepartment of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia.
Hong WangDepartment of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia.
Gail P RisbridgerDepartment of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia.
Nicole M HaynesSir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.
Mikolaj MedonCancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Ricky W JohnstoneSir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.
Eva VidacsCancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Gisela Mir ArnauMolecular Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Ismael A VergaraThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Anthony T PapenfussSir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.
Grant McArthurDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Paul WaringDepartment of Pathology, the University of Melbourne, Parkville, Victoria, Australia.
Shirley CarvossoThe Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Christopher AngelDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
David GyorkiDivision of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Benjamin SolomonDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Gillian MitchellSir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.
Sue ShanleyThe Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Prudence A FrancisDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sarah-Jane DawsonDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Amy HaffendenDepartment of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Erin TidballDepartment of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Mila VolchekDepartment of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia.
Jan PymanDepartment of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia.
Mohammed MadadinThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.ORCID 0000-0002-8594-5868
Jodie LeditschkeThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Stephen CordnerThe Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
Melbourne Melanoma Project
Australian Ovarian Cancer Study Group (AOCS)
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
Mark ShackletonDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-7673-4655
David D BowtellCancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AutopsyBiotechnologyCommunity-Institutional RelationsFemaleGenetic TechniquesHumansImmunohistochemistryMaleModels, TheoreticalNeoplasmsPatient SelectionTime Factors
Identifiers
PMID
27617737What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.